Eli Lilly stock is experiencing significant attention ahead of earnings, with some outlets suggesting it may be headed higher, while others question if it has become too expensive to buy. The stock has recently hit a new all-time high, and some analysts are boosting its price target. The outlook for the stock is uncertain, with conflicting predictions about its future direction.